Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer.

Sabrina A MaiselDerrick BrokaBenjamin AtwellThomas BunchRobert KuppShiv K SinghShwetal MehtaJoyce Schroeder

Published in: Journal of translational medicine (2019)

Taken together, these data indicate that SAH-EJ1 may be an effective therapeutic for HER-driven cancers with the potential to eliminate triple negative inflammatory breast cancer.

Keyphrases

small cell lung cancer
oxidative stress
papillary thyroid
childhood cancer
epidermal growth factor receptor
electronic health record
tyrosine kinase
machine learning
young adults
breast cancer risk
risk assessment
climate change
artificial intelligence
lymph node metastasis